Acute pancreatitis following ifosfamide.
Izraeli S, Adamson PC, Blaney SM, Balis FM, Cancer; 74(5):1627-1628A phase I trial of amifostine (WR-2721) and melphalan in pediatric patients with advanced neoplastic disease.
Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG, Cancer Res; 55:4069-4072Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.
Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM, Cancer Res; 55(3):482-485Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC, Bailey J, Pluda J, Poplack DG, Bauza S, Murphy RF, Yarchoan R, Balis FM, J Clin Oncol; 13(5):1238-1241Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
Bailey J, Pluda JM, Foli A, Saville MW, Bauza S, Adamson PC, Murphy RF, Cohen RB, Broder S, Yarchoan R, J Clin Oncol;13(8):1966-1974Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC, Cancer; 76(3):521-526Pharmacology and drug resistance in childhood lymphoblastic leukemia.
Adamson PC, Poplack DG, Balis FM, Hematol Oncol Clin North Am; 4(5):871-894The child with recurrent solid tumor.
Adamson PC, Horowitz ME, Poplack DG, Pediatr Clin North Am; 38(2):489-504Reinvestigation of the matrix IR spectrum of peroxyacetylnitrate (PAN).
Adamson P, Gunthard HH, Spectrochim ActaPhase II evaluation of topotecan for pediatric central nervous system tumors.
Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RL, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM, Cancer; 78(3):527-531Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study
Horton TM, Thompson PA, Berg SL, Adamson PC, Ingle AM, Dolan ME, Delaney SM, Hedge M, Weiss HL, Wu MF, Blaney SM., J Clin OncolSuccessful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.
O'Marcaigh AS, Johnson CM, Smithson WA, Patterson MC, Widemann BC, Adamson PC, McManus MJ, Mayo Clin Proc; 71(2):161-165Pharmacokinetic variability and apparent drug resistance.
Adamson PC, Poplack DG, Int J Pediatr Hematol Oncol; 4(6):525-530Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule with interferon-alfa-2a in pediatric patients with refracto...
Adamson PC, Reaman G, Finkelstein JZ, Feusner J, Berg SL, Blaney SM, O'Brien M, Murphy RF, Balis FM, J Clin Oncol;15(11):3330-3337Pediatric phase I trial of Docetaxel administered as a 1-hour infusion: A collaborative Pediatric Branch, National Cancer Institute and Children’s Cancer Group trial.
Blaney SM, Seibel N, O’Brien M, Reaman G, Berg SL, Adamson PC, Poplack DG, Krailo MD, Mosher R, Balis FM, J Clin Oncol; 15(4):1538-1543Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd GT, Adamson PC, Gupta M, Sandstrom K, McLain D, Tuason L, Peereboom D, Bukowski RM, Ganapathi R, Clin. Cancer Res; 4:635-642A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Kitchen BJ, Balis FM, Poplack DG, O'Brien M, Craig CE, Adamson PC, Clin Cancer Res; 3(5):713-7Carboxypeptidase-G2, thymidine and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC, Balis FM, Murphy RF, Sorenson MJ, Montello MJ, O’Brien M, Adamson PC, J Clin Oncol; 15(5):2125-2134Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
Berg SL, Blaney SM, Adamson PC, O'Brien M, Poplack DG, Arndt C, Blatt J, Balis FM, J Clin Oncol;16(1):181-186Phase II trial of topotecan administered as a 72-hour continuous infusion in children with refractory solid tumors: A Collaborative Pediatric Branch, National Cancer I...
Blaney S, Needle M, Gillespie A, Sato J, Reaman G, Berg S, Adamson P, Krailo M, Bleyer W, Poplack D, Balis F, Clin Cancer Res;4:357-360Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.
Kitchen BJ, Moser A, Lowe E, Balis FM, Brigitte Widemann, Anderson L, Strong J, Blaney SM, Berg SL, O’Brien M, Adamson PC, J Pharmacol Exp Ther; 291:870–874Intraventricular concentration times time (CxT) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM, Adamson PC, Gillespie AJ, Poplack DG, Balis FM, Cancer; 85(2):511-516Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.
Widemann BC, Balis FM, Adamson PC, Clin Chem; 45(2):223-8The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model.
Widemann BC, Balis FM, Godwin KS, McCully C, Adamson PC, Cancer Chemother Pharmacol; 44(6):439-43Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia.
Longui CA, Vottero A, Adamson PC, Cole DE, Kino T, Monte O, Chrousos GP, Horm Metab Res; 32(10):401-6- Join now to see all